VAPO - Vapotherm high velocity therapy outperforms in children with asthma
2023-09-25 07:49:02 ET
More on Vapotherm
- Seeking Alpha’s Quant Rating on Vapotherm
- Historical earnings data for Vapotherm
- Financial information for Vapotherm
- Vapotherm, Inc. (VAPO) Q2 2023 Earnings Call Transcript
- Vapotherm reports mixed Q2 earnings; updates FY23 outlook
For further details see:
Vapotherm high velocity therapy outperforms in children with asthma